CD28 Costimulation: From Mechanism to Therapy

被引:645
作者
Esensten, Jonathan H. [1 ]
Helou, Ynes A. [2 ]
Chopra, Gaurav [3 ]
Weiss, Arthur [2 ,4 ]
Bluestone, Jeffrey A. [5 ,6 ]
机构
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Rheumatol R, San Francisco, CA 94143 USA
[3] Purdue Univ, Dept Chem, Purdue Ctr Drug Discovery, W Lafayette, IN 47907 USA
[4] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
REGULATORY T-CELLS; KAPPA-B ACTIVATION; TYROSINE PHOSPHORYLATION SITES; PROTEIN ARGININE METHYLATION; CUTTING EDGE; C-REL; PHOSPHATIDYLINOSITOL; 3-KINASE; CRYSTAL-STRUCTURE; IMMUNOLOGICAL SYNAPSE; CYTOPLASMIC DOMAIN;
D O I
10.1016/j.immuni.2016.04.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ligation of the CD28 receptor on T cells provides a critical second signal alongside T cell receptor (TCR) ligation for naive T cell activation. Here, we discuss the expression, structure, and biochemistry of CD28 and its ligands. CD28 signals play a key role in many T cell processes, including cytoskeletal remodeling, production of cytokines, survival, and differentiation. CD28 ligation leads to unique epigenetic, transcriptional, and post-translational changes in T cells that cannot be recapitulated by TCR ligation alone. We discuss the function of CD28 and its ligands in both effector and regulatory T cells. CD28 is critical for regulatory T cell survival and the maintenance of immune homeostasis. We outline the roles that CD28 and its family members play in human disease and we review the clinical efficacy of drugs that block CD28 ligands. Despite the centrality of CD28 and its family members and ligands to immune function, many aspects of CD28 biology remain unclear. Translation of a basic understanding of CD28 function into immunomodulatory therapeutics has been uneven, with both successes and failures. Such real-world results might stem from multiple factors, including complex receptor-ligand interactions among CD28 family members, differences between the mouse and human CD28 families, and cell-type specific roles of CD28 family members.
引用
收藏
页码:973 / 988
页数:16
相关论文
共 205 条
[101]   Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity [J].
Manavalan, JS ;
Kim-Schulze, S ;
Scotto, L ;
Naiyer, AJ ;
Vlad, G ;
Colombo, PC ;
Marboe, C ;
Mancini, D ;
Cortesini, R ;
Suciu-Foca, N .
INTERNATIONAL IMMUNOLOGY, 2004, 16 (08) :1055-1068
[102]   CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-κB subunits on IL-8 and Bcl-xL gene promotors [J].
Marinari, B ;
Costanzo, A ;
Marzano, V ;
Piccolella, E ;
Tuosto, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (16) :6098-6103
[103]  
MARTIN PJ, 1986, J IMMUNOL, V136, P3282
[104]   Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes [J].
McClymont, Stephanie A. ;
Putnam, Amy L. ;
Lee, Michael R. ;
Esensten, Jonathan H. ;
Liu, Weihong ;
Hulme, Maigan A. ;
Hoffmueller, Ulrich ;
Baron, Udo ;
Olek, Sven ;
Bluestone, Jeffrey A. ;
Brusko, Todd M. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (07) :3918-3926
[105]   Abatacept in the Treatment of Patients With Psoriatic Arthritis [J].
Mease, Philip ;
Genovese, Mark C. ;
Gladstein, Geoffrey ;
Kivitz, Alan J. ;
Ritchlin, Christopher ;
Tak, Paul P. ;
Wollenhaupt, Juergen ;
Bahary, Orna ;
Becker, Jean-Claude ;
Kelly, Sheila ;
Sigal, Leonard ;
Teng, Julie ;
Gladman, Dafna .
ARTHRITIS AND RHEUMATISM, 2011, 63 (04) :939-948
[106]   The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial [J].
Merrill, J. T. ;
Burgos-Vargas, R. ;
Westhovens, R. ;
Chalmers, A. ;
D'Cruz, D. ;
Wallace, D. J. ;
Bae, S. C. ;
Sigal, L. ;
Becker, J. -C. ;
Kelly, S. ;
Raghupathi, K. ;
Li, T. ;
Peng, Y. ;
Kinaszczuk, M. ;
Nash, P. .
ARTHRITIS AND RHEUMATISM, 2010, 62 (10) :3077-3087
[107]   Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28 [J].
Metzler, WJ ;
Bajorath, J ;
Fenderson, W ;
Shaw, SY ;
Constantine, KL ;
Naemura, J ;
Leytze, G ;
Peach, RJ ;
Lavoie, TB ;
Mueller, L ;
Linsley, PS .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (07) :527-531
[108]  
Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180
[109]   Single Administration of p2TA (AB103), a CD28 Antagonist Peptide, Prevents Inflammatory and Thrombotic Reactions and Protects against Gastrointestinal Injury in Total-Body Irradiated Mice [J].
Mirzoeva, Salida ;
Paunesku, Tatjana ;
Wanzer, M. Beau ;
Shirvan, Anat ;
Kaempfer, Raymond ;
Woloschak, Gayle E. ;
Small, William, Jr. .
PLOS ONE, 2014, 9 (07)
[110]   CD28 Negative T Cells: Is Their Loss Our Gain? [J].
Mou, D. ;
Espinosa, J. ;
Lo, D. J. ;
Kirk, A. D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (11) :2460-2466